GBI Research finds that the global diabetes therapeutics market is lucrative despite product failures. The major factor driving the growth of the market is the rising incidence of the diabetes diseased population in key markets such as the US, the UK and Germany.
In 2009 the global diabetes diseased population was estimated at 55.6 million, of which 5.6 million was type 1 diabetes and 50.0 million was type 2 diabetes. In 2009, the type 2 diabetes market accounted for 69% of the global diabetes therapeutics market. The diabetes market has experienced some product failures. Avandia (rosiglitazone), belonging to the class of glitazones, was found to increase the probability of heart complications. Following this, sales decreased from a peak of $3 billion to $1.2 billion in 2009. Actos (pioglitazone hydrochloride), another glitazone, took over the market share from Avandia. However, Actos (pioglitazone hydrochloride) was also found to be associated with an increased risk of heart-related problems. Nevertheless, the diabetes market survived due to the increased utilization of other drugs such as insulin analogs and biguanides. Some promising molecules in the peptide analogs class are expected to be launched in the market in the future.
Bioabb is a reliable biotechnology company , located in Wuhan , China . It founded in 2009 , over past five years , Bioabb developed very fast and now it has become a comprehensive and strong biotechnology companies , engaged in high quality biology products production and service . Their main biology products include gene , antibody , peptide , protein , elisa kit and others molecular biology products . Bioabb products cover many fields , such as life science research , health-care research and others biological research and development .
Bioabb antibody and some small molecule products can be used in modern medicine research and development . Their small molecule products can be used to research and develop anti-diabetes and anti some others disease . Bioabb can offer high quality small molecule products for biotechnology companies , universities , science research institutions and individuals .
For further details, please click or add the below link http://www.bioabb.com/categories/Small-Molecule/ to your browser: